MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals informs about Board Meeting

25 Apr 2013 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on May 07, 2013, to consider, approval of unaudited financial results for the quarter ended March 31, 2013 (Q1).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1855.00
Dr. Reddys Labs. 1147.20
Cipla 1359.00
Lupin 2046.00
Zydus Lifesciences 1110.20
View more..